The combination of sulfamethoxazole (SMZ) and trimethoprim (TMP) in a 5: 1 ratio has not previously been evaluated as the sole antimicrobial agent in treatment of bacterial endocarditis. Bacteremia was suppressed in three patients with Streptococcus viridans endocarditis; however, one patient relapsed three days after cessation of therapy. Two patients treated for six and eight weeks for Pseudomonas cepacia endocarditis relapsed within two weeks of stopping chemotherapy. In one patient with endocarditis due to a susceptible Staphylococcus aureus,. treatment was stopped after two days because of lack of clinical improvement and of increasing numbers of organisms on quantitative blood cultures. Review of the literature suggests that administration of polymyxin or another appropriate antimicrobial agent may increase the effectiveness of TMP-SMZ in the treatment of bacterial endocarditis. Since effective antibacterial therapy is available for many organisms causing endocarditis, future evaluation of TMP-SMZ in endocarditis should be limited to those situations in which either no other effective therapy is known or host factors such as allergy to penicillin exist.
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Reeves estimated in 1971 that 40 million tablets of trimethoprim (TMP ) and sulfamethoxazole (SMZ) had been administered to humans but was able to cite few instances in which the combination had been administered for the treatment of bacterial endocarditis [1] . Unfortunately, concurrent administration of additional antimicrobial agents complicates interpretation of the results. Darrell et al. treated a patient who had Enterobacter aerogenes endocarditis with SMZ, TMP, and polymyxin [2] . Blood cultures became sterile, but the patient died. Fowle and Zorab successfully treated a patient with Escherichia coli endocarditis [3] ; however colistin and cephaloridine were used concomitantly with TMP-SMZ. Shafqat three patients receiving parenteral infusions [5] . Two patients treated with TMP-SMZ were cured, but kanamycin was also administered (see addendum). Freeman and Hodson successfully used TMP-SMZ and tetracycline to treat a patient diagnosed as having Q fever endocarditis [6] .
This study describes the treatment of six patients with bacterial endocarditis. The combination of TMP and SMZ was administered as the sole antimicrobial agent for the entire course of treatment or until a decision was made that treatment had failed. In addition, the literature was reviewed for additional cases of endocarditis and for bacteremias caused by organisms other than Salmonella typhi or Brucella.
Materials and Methods
Tube dilution sensitivity test. Oxoid sensitivity test broth, (Consolidated Laboratories, Chicago Heights, TIL) was used both as growth media and as diluent. Horse serum (2.5%) was added to promote growth of the Streptococcus viridans isolated from patient CJ. In testing susceptibility to a single antimicrobial agent, 0.5 ml of a 10-4 dilution of an overnight culture inoculated from a single colony was added to a series of tubes containing twofold dilutions of 0.5 ml Table 1 . Comparison of the results of tube dilution sensitivity tests to trimethoprim (TMP) and sulfamethoxazole (SMZ) done with present materials and methods and the results of Bushby [7] .
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Mueller [7] as control to evaluate the current methods and the batch of Oxoid broth (table 1). The TSA used for testing bactericidal activity was found to contain substances inhibitory to SMZ and TMP as judged by comparison of zone sizes in disk diffusion tests on Mueller-Hinton agar with the Kirby-Bauer method, and those done on TSA (table 2) .
Serum antibacterial activity. Bacteriostatic and bactericidal activity in serum of patients receiving treatment was estimated by methods similar to those described above for MIC and MBC, respectively. Twofold dilutions of serum were made in Oxoid broth.
Quantitative blood cultures. Approximately 2 ml of blood drawn immediately before the next dose of TMP-SMZ were added to dried sterile citrate. One millilter of the citrated blood was mixed with 18 ml of liquefied TSA previously cooled to 45 C. The mixture was then poured into petri dishes, and the number of colonies was counted after incubation for two to three days. third patient (RG) had an organism with relatively high MIC both to SMZ (32 ug/rnl) and to TMP (8 ug/ml), but in combination the MIC of SMZ was 4 ug/rnl, and of trimethoprim .25 ug/rnl. He was treated with more frequent doses, receiving the tablets every 8 hr; but only for three weeks. Blood cultures were negative on the first day of treatment. Blood cultures taken on the third day after cessation of treatment were positive, and he was successfully retreated with a twoweek course of phenoxymethyl penicillin and streptomycin. P. cepacia (two patients). The first patient (WM) was still bacteremic after 27 days of kanamycin therapy (figure 1). Chloramphenicol had also been administered from the second to the 19th day of kanamycin treatment but was discontinued because disk tests suggested antagonism between the two antibiotics, because no antibacterial activity was detected in the serum, and most importantly, because blood cultures again became positive. On the continued administration of kanamycin alone the blood cultures became transiently negative, but the patient remained febrile. The. patient was started on 160 mg of TMP and 800 mg of SMZ every 12 hr. Kanamycin was stopped. A blood culture drawn before the start of TMP-SMZ therapy was positive, but all cultures during that treatment were sterile. Treatment with TMP-SMZ was continued for SIX weeks, during which time he developed aortic insufficiency. Bacteriostatic activity on serial specimens of the patient's serum drawn 2 hr after a dose gradually increased from a titer of 1: 8 to 1: 64. A blood culture taken three days after treatment ended was sterile, and the patient remained afebrile for at least five days; however, a blood culture taken in the outpatient department 13 days after cessation of treatment with TMP-SMZ grew P. cepacia. He was readmitted with severe congestive heart failure and died during an attempted second course of treatment. The second patient (PS) was treated with the combination of TMP-SMZ every 8 hr for two months. In vitro studies indicated MIC and MBC of 1: 16 and 2: 32, respectively, of the TMP-SMZ combination. He continued to be febrile for seven days after start of treatment, and blood cultures were positive with irregularly decreasing numbers of bacteria for 10 days. Blood cultures were taken daily after cessation of treatment and became positive on the sixth day. The patient then developed aortic insufficiency, and emergency aortic valve replacement was done. P. cepacia was cultured from vegetations on the valve. He died three days after the operation.
S. aureus (one patient). Although we usually administer a penicillinase-resistant penicillin or cephalosporin to addicts suspected of having staphylococcal bacteremia, this patient was initially treated with 2 million units of benzylpenicillin iv every 2 hr for two days. His organism was resistant to penicillin when tested by the disk diffusion method, and the number of viable staphylococcal units in his blood increased from 78 to 380/ml. The penicillin was stopped. TMP-SMZ was given, two tablets every 12 hr for one day and every 8 hr for a second. The MIC and MBC of the TMP-SMZ combination were~.03:.5 and >32:512, respectively. He continued to be febrile, and the number of viable units increased to 650/ml. Methicillin, 1 g iv every 2 hr, was added. A quantitative blood culture drawn 2 hr after the first methicillin dose grew two colonies per ml in spite of the presence of 10 4 Kersey units/ ml of Bacillus cereus penicillinase (Baltimore Biological Laboratories, Baltimore, Md.). TMP-SMZ was stopped, and the patient recovered with methicillin therapy after having complications including multiple pulmonary emboli and pericardial effusion.
Complications of therapy. RG developed a low grade fever on the eighth day of treatment, which gradually increased to 102.6 F on the 13th day, at which time he developed pain and swelling in his left ankle. Both fever and arthritis abated promptly with the administration of diphenhydramine, 25 mg orally every 8 hr. WM, who had sickle cell disease with severe anemia, was found to have megaloblastic changes in his bone marrow on the 16th day of treatment and was given citrovorum factor. Folic acid therapy had been stopped with the onset of TMP therapy. In retrospect he could have developed folate deficiency, as is sometimes seen in patients with severe sickle cell anemia. Folic acid should not have been stopped since TMP-sensitive bacteria are unable to use exogenous folates.
Discussion
The four previously reported cases of bacterial endocarditis treated with TMP-SMZ had also received other antimicrobial agents (table 6) . Cure was achieved in three patients, and in the fourth, who died shortly after the addition of TMP-SMZ, blood cultures became sterile. Ten patients with septicemias in infections other than typhoid fever or brucellosis had been treated solely with TMP-SMZ (table 7) . Seven were apparently cured (four with staphylococcal osteomyelitis, one with staphylococcal septic arthritis, one with E. coli abscess of the broad ligament, and one with S759 Citrobacter ireundii urinary tract infection). One patient with staphylococcal osteomyelitis was still under treatment at the time of report. A patient with staphylococcal septicemia of obscure origin failed to respond after 28 days of therapy but was subsequently cured with vancomycin. A patient with Proteus species septicemia died after five days of treatment. Three additional patients with septicemia received concurrent therapy with other antimicrobial agents, and all survived (table   8) .
Because of insufficient data in the original 'reports, the following patients were not included in the tables; three patients of Darrell et al. in whom treatment failed had bacteroides septicemia [2] . In two of these patients postabortion E. coli septicemia was eradicated, but superinfection with Bacteroides species occurred. A patient of Geddes et al. with a clinical picture of enteric fever, previously undiagnosed aortic incompetence, and splinter hemorrhages, had Salmonella paratyphi B septicemia [8] . He was successfully treated with TMP-SMZ. Two patients of Phillips et al. had P. cepacia septicemia following insertion of prosthetic aortic valves [9] . They were not included since blood cultures were apparently not positive immediately before treatment with TMP-SMZ. Three patients of Speller et al. probably had infections of prosthetic valves with P. cepacia [5] . In two of these, successful treatment was achieved with TMP-SMZ, but kanamycin was also administered (see addendum).
The review of the literature indicates that only small numbers of patients with blood stream infections other than those accompanying typhoid fever or brucellosis have been treated with TMP-SMZ either alone or in combination with other antimicrobial agents.
Although control of bacteremia occurred in 13 patients treated solely with TMP-SMZ, bacteremias in three patients with organisms susceptible by in vitro testing (Proteus mirabilis [10] , Staphylococcus aureus [11], present report) were not suppressed by TMP-SMZ alone. Only two of the six patients with bacterial endocarditis in the present series were successfully treated with TMP-SMZ alone. In vitro studies demonstrated bactericidal activity in serum of three of the four therapeutic failures. The suppression of P. cepacia bacteremia wag. noteworthy in that bacteremia in a previous patient with P. cepacia endocarditis was not controlled by more conventional therapy [12] .
The reports of successful treatment of two cases of P. mirabilis septicemia [13, 14] , and one case of E. coli endocarditis [3] are impressive instances indicating effectiveness of TMP-SMZ when used in combinations with antimicrobial agents which include a polymyxin. These reports raise the possibility that the addition of a third antimicrobial agent may be necessary to help reduce a large infectious inoculum and to increase bactericidal activity. Although the combination of TMP-SMZ has proved effective in many types of infections, the usefulness of this combination alone in patients with septicemias and endocarditis remains to be established.
